메뉴 건너뛰기




Volumn 25, Issue 5, 2011, Pages 639-645

Weight changes over time in adults treated with the oral or depot formulations of olanzapine: A pooled analysis of 86 clinical trials

Author keywords

BMI; olanzapine; weight

Indexed keywords

OLANZAPINE;

EID: 79955384195     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881110370505     Document Type: Article
Times cited : (22)

References (12)
  • 1
    • 0035041926 scopus 로고    scopus 로고
    • Antipsychotic-induced weight gain: A review of the literature
    • Allison DB, Casey DE. Antipsychotic-induced weight gain: a review of the literature. J Clin Psychiatry. 2001 ; 62 (suppl 7). 22-31 (Pubitemid 32402182)
    • (2001) Journal of Clinical Psychiatry , vol.62 , Issue.SUPPL. 7 , pp. 22-31
    • Allison, D.B.1    Casey, D.E.2
  • 3
    • 60949099657 scopus 로고    scopus 로고
    • Antipsychotic-induced body weight gain: Predictors and a systematic categorization of the long-term weight course
    • Gebhardt S, Haberhausen M, Heinzel-Gutenbrunner M, et al. Antipsychotic-induced body weight gain: predictors and a systematic categorization of the long-term weight course. J Psychiatr Res. 2009 ; 43: 620-626
    • (2009) J Psychiatr Res , vol.43 , pp. 620-626
    • Gebhardt, S.1    Haberhausen, M.2    Heinzel-Gutenbrunner, M.3
  • 4
    • 0035108241 scopus 로고    scopus 로고
    • Long-term olanzapine treatment: Weight change and weight-related health factors in schizophrenia
    • Kinon BJ, Basson BR, Gilmore JA, Tollefson GD. Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia. J Clin Psychiatry. 2001 ; 62: 92-100 (Pubitemid 32199865)
    • (2001) Journal of Clinical Psychiatry , vol.62 , Issue.2 , pp. 92-100
    • Kinon, B.J.1    Basson, B.R.2    Gilmore, J.A.3    Tollefson, G.D.4
  • 7
    • 79955399654 scopus 로고    scopus 로고
    • Metabolic parameters in patients treated with olanzapine or other atypical antipsychotics (abstract)
    • Osuntokun O, Millen B, Xu I, et al. Metabolic parameters in patients treated with olanzapine or other atypical antipsychotics (abstract). Schizophr Res. 2008 ; 102 (suppl 2). 243-243
    • (2008) Schizophr Res , vol.102 , Issue.SUPPL. 2 , pp. 243-243
    • Osuntokun, O.1    Millen, B.2    Xu, I.3
  • 9
    • 58249129947 scopus 로고    scopus 로고
    • Glucose and lipid disturbances after 1 year of antipsychotic treatment in a drug-naïve population
    • Perez-Iglesias R, Mata I, Pelayo-Teran JM, et al. Glucose and lipid disturbances after 1 year of antipsychotic treatment in a drug-naïve population. Schizophr Res. 2009 ; 107: 115-121
    • (2009) Schizophr Res , vol.107 , pp. 115-121
    • Perez-Iglesias, R.1    Mata, I.2    Pelayo-Teran, J.M.3
  • 10
    • 0037708783 scopus 로고    scopus 로고
    • The implications of weight changes with antipsychotic treatment
    • Sussman N. The implications of weight changes with antipsychotic treatment. J Clin Psychopharmacol. 2003 ; 23 (3 suppl 1). S21 - S26
    • (2003) J Clin Psychopharmacol , vol.23 , Issue.3 SUPPL. 1
    • Sussman, N.1
  • 11
    • 64749083959 scopus 로고    scopus 로고
    • Effects of six second generation antipsychotics on body weight and metabolism - Risk assessment and results from a prospective study
    • Tschoner A, Engl J, Rettenbacher M, et al. Effects of six second generation antipsychotics on body weight and metabolism - risk assessment and results from a prospective study. Pharmacopsychiatry. 2009 ; 42: 29-34
    • (2009) Pharmacopsychiatry , vol.42 , pp. 29-34
    • Tschoner, A.1    Engl, J.2    Rettenbacher, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.